Serveur d'exploration sur la COVID en France

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.

Identifieur interne : 000951 ( Main/Exploration ); précédent : 000950; suivant : 000952

Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.

Auteurs : Markus Zeitlinger [Autriche] ; Birgit C P. Koch [Pays-Bas] ; Roger Bruggemann [Pays-Bas] ; Pieter De Cock [Belgique] ; Timothy Felton [Royaume-Uni] ; Maya Hites [Belgique] ; Jennifer Le [États-Unis] ; Sonia Luque [Espagne] ; Alasdair P. Macgowan [Royaume-Uni] ; Deborah J E. Marriott [Australie] ; Anouk E. Muller [Pays-Bas] ; Kristina Nadrah [Slovénie] ; David L. Paterson [Australie] ; Joseph F. Standing [Royaume-Uni] ; João P. Telles [Brésil] ; Michael Wölfl-Duchek [Autriche] ; Michael Thy [France] ; Jason A. Roberts [Australie, France]

Source :

RBID : pubmed:32725382

Abstract

There is an urgent need to identify optimal antiviral therapies for COVID-19 caused by SARS-CoV-2. We have conducted a rapid and comprehensive review of relevant pharmacological evidence, focusing on (1) the pharmacokinetics (PK) of potential antiviral therapies; (2) coronavirus-specific pharmacodynamics (PD); (3) PK and PD interactions between proposed combination therapies; (4) pharmacology of major supportive therapies; and (5) anticipated drug-drug interactions (DDIs). We found promising in vitro evidence for remdesivir, (hydroxy)chloroquine and favipiravir against SARS-CoV-2; potential clinical benefit in SARS-CoV-2 with remdesivir, the combination of lopinavir/ritonavir (LPV/r) plus ribavirin; and strong evidence for LPV/r plus ribavirin against Middle East Respiratory Syndrome (MERS) for post-exposure prophylaxis in healthcare workers. Despite these emerging data, robust controlled clinical trials assessing patient-centred outcomes remain imperative and clinical data have already reduced expectations with regard to some drugs. Any therapy should be used with caution in the light of potential drug interactions and the uncertainty of optimal doses for treating mild versus serious infections.

DOI: 10.1007/s40262-020-00924-9
PubMed: 32725382
PubMed Central: PMC7385074


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.</title>
<author>
<name sortKey="Zeitlinger, Markus" sort="Zeitlinger, Markus" uniqKey="Zeitlinger M" first="Markus" last="Zeitlinger">Markus Zeitlinger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea>
<placeName>
<settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koch, Birgit C P" sort="Koch, Birgit C P" uniqKey="Koch B" first="Birgit C P" last="Koch">Birgit C P. Koch</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Hospital Pharmacy, Erasmus MC, Rotterdam</wicri:regionArea>
<placeName>
<settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bruggemann, Roger" sort="Bruggemann, Roger" uniqKey="Bruggemann R" first="Roger" last="Bruggemann">Roger Bruggemann</name>
<affiliation wicri:level="3">
<nlm:affiliation>Radboud University Medical Center, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud University Medical Center, Nijmegen</wicri:regionArea>
<placeName>
<settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De Cock, Pieter" sort="De Cock, Pieter" uniqKey="De Cock P" first="Pieter" last="De Cock">Pieter De Cock</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmacy 2, Heymans Institute of Pharmacology, Ghent University Hospital, Ghent University, Ghent, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Pharmacy 2, Heymans Institute of Pharmacology, Ghent University Hospital, Ghent University, Ghent</wicri:regionArea>
<wicri:noRegion>Ghent</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Felton, Timothy" sort="Felton, Timothy" uniqKey="Felton T" first="Timothy" last="Felton">Timothy Felton</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hites, Maya" sort="Hites, Maya" uniqKey="Hites M" first="Maya" last="Hites">Maya Hites</name>
<affiliation wicri:level="4">
<nlm:affiliation>Clinic of Infectious Diseases, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Clinic of Infectious Diseases, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author>
<name sortKey="Le, Jennifer" sort="Le, Jennifer" uniqKey="Le J" first="Jennifer" last="Le">Jennifer Le</name>
<affiliation wicri:level="2">
<nlm:affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Luque, Sonia" sort="Luque, Sonia" uniqKey="Luque S" first="Sonia" last="Luque">Sonia Luque</name>
<affiliation wicri:level="3">
<nlm:affiliation>Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar D'Investigacions Mèdiques (IMIM), Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar D'Investigacions Mèdiques (IMIM), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Macgowan, Alasdair P" sort="Macgowan, Alasdair P" uniqKey="Macgowan A" first="Alasdair P" last="Macgowan">Alasdair P. Macgowan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Bristol Centre for Antimicrobial Research and Evaluation, Infection Sciences, Severn Pathology Partnership, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, Bristol, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Bristol Centre for Antimicrobial Research and Evaluation, Infection Sciences, Severn Pathology Partnership, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, Bristol</wicri:regionArea>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Marriott, Deborah J E" sort="Marriott, Deborah J E" uniqKey="Marriott D" first="Deborah J E" last="Marriott">Deborah J E. Marriott</name>
<affiliation wicri:level="1">
<nlm:affiliation>St. Vincent's Hospital, Darlinghurst, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>St. Vincent's Hospital, Darlinghurst, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of New South Wales, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of New South Wales, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Anouk E" sort="Muller, Anouk E" uniqKey="Muller A" first="Anouk E" last="Muller">Anouk E. Muller</name>
<affiliation wicri:level="3">
<nlm:affiliation>HaaglandenMC, The Hague and ErasmusMC, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>HaaglandenMC, The Hague and ErasmusMC, Rotterdam</wicri:regionArea>
<placeName>
<settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nadrah, Kristina" sort="Nadrah, Kristina" uniqKey="Nadrah K" first="Kristina" last="Nadrah">Kristina Nadrah</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.</nlm:affiliation>
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.</nlm:affiliation>
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Faculty of Medicine, University of Ljubljana, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Paterson, David L" sort="Paterson, David L" uniqKey="Paterson D" first="David L" last="Paterson">David L. Paterson</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Standing, Joseph F" sort="Standing, Joseph F" uniqKey="Standing J" first="Joseph F" last="Standing">Joseph F. Standing</name>
<affiliation wicri:level="4">
<nlm:affiliation>Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">University College de Londres</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pharmacy, Great Ormond Street Hospital for Children, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy, Great Ormond Street Hospital for Children, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Telles, Joao P" sort="Telles, Joao P" uniqKey="Telles J" first="João P" last="Telles">João P. Telles</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP</wicri:regionArea>
<placeName>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wolfl Duchek, Michael" sort="Wolfl Duchek, Michael" uniqKey="Wolfl Duchek M" first="Michael" last="Wölfl-Duchek">Michael Wölfl-Duchek</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Clinical Pharmacology, Medical University of Vienna, Vienna</wicri:regionArea>
<placeName>
<settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Thy, Michael" sort="Thy, Michael" uniqKey="Thy M" first="Michael" last="Thy">Michael Thy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Infectious Diseases Department and Intensive Care Unit, Hospital Bichat, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Infectious Diseases Department and Intensive Care Unit, Hospital Bichat, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>EA7323, Evaluation of Perinatal and Paediatric Therapeutics and Pharmacology, University Paris Descartes, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>EA7323, Evaluation of Perinatal and Paediatric Therapeutics and Pharmacology, University Paris Descartes, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Queensland Centre for Clinical Research, Faculty of Medicine and Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland Centre for Clinical Research, Faculty of Medicine and Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>The University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029</wicri:regionArea>
<wicri:noRegion>4029</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32725382</idno>
<idno type="pmid">32725382</idno>
<idno type="doi">10.1007/s40262-020-00924-9</idno>
<idno type="pmc">PMC7385074</idno>
<idno type="wicri:Area/Main/Corpus">000806</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000806</idno>
<idno type="wicri:Area/Main/Curation">000806</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000806</idno>
<idno type="wicri:Area/Main/Exploration">000806</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.</title>
<author>
<name sortKey="Zeitlinger, Markus" sort="Zeitlinger, Markus" uniqKey="Zeitlinger M" first="Markus" last="Zeitlinger">Markus Zeitlinger</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna</wicri:regionArea>
<placeName>
<settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Koch, Birgit C P" sort="Koch, Birgit C P" uniqKey="Koch B" first="Birgit C P" last="Koch">Birgit C P. Koch</name>
<affiliation wicri:level="3">
<nlm:affiliation>Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Hospital Pharmacy, Erasmus MC, Rotterdam</wicri:regionArea>
<placeName>
<settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bruggemann, Roger" sort="Bruggemann, Roger" uniqKey="Bruggemann R" first="Roger" last="Bruggemann">Roger Bruggemann</name>
<affiliation wicri:level="3">
<nlm:affiliation>Radboud University Medical Center, Nijmegen, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>Radboud University Medical Center, Nijmegen</wicri:regionArea>
<placeName>
<settlement type="city">Nimègue</settlement>
<region type="province" nuts="2">Gueldre</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="De Cock, Pieter" sort="De Cock, Pieter" uniqKey="De Cock P" first="Pieter" last="De Cock">Pieter De Cock</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmacy 2, Heymans Institute of Pharmacology, Ghent University Hospital, Ghent University, Ghent, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Pharmacy 2, Heymans Institute of Pharmacology, Ghent University Hospital, Ghent University, Ghent</wicri:regionArea>
<wicri:noRegion>Ghent</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Felton, Timothy" sort="Felton, Timothy" uniqKey="Felton T" first="Timothy" last="Felton">Timothy Felton</name>
<affiliation wicri:level="4">
<nlm:affiliation>Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
<orgName type="university">Université de Manchester</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester</wicri:regionArea>
<placeName>
<settlement type="city">Manchester</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hites, Maya" sort="Hites, Maya" uniqKey="Hites M" first="Maya" last="Hites">Maya Hites</name>
<affiliation wicri:level="4">
<nlm:affiliation>Clinic of Infectious Diseases, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Clinic of Infectious Diseases, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels</wicri:regionArea>
<placeName>
<settlement type="city">Bruxelles</settlement>
<region nuts="2">Région de Bruxelles-Capitale</region>
</placeName>
<orgName type="university">Université libre de Bruxelles</orgName>
</affiliation>
</author>
<author>
<name sortKey="Le, Jennifer" sort="Le, Jennifer" uniqKey="Le J" first="Jennifer" last="Le">Jennifer Le</name>
<affiliation wicri:level="2">
<nlm:affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Luque, Sonia" sort="Luque, Sonia" uniqKey="Luque S" first="Sonia" last="Luque">Sonia Luque</name>
<affiliation wicri:level="3">
<nlm:affiliation>Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar D'Investigacions Mèdiques (IMIM), Barcelona, Spain.</nlm:affiliation>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar D'Investigacions Mèdiques (IMIM), Barcelona</wicri:regionArea>
<placeName>
<settlement type="city">Barcelone</settlement>
<region nuts="2" type="region">Catalogne</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Macgowan, Alasdair P" sort="Macgowan, Alasdair P" uniqKey="Macgowan A" first="Alasdair P" last="Macgowan">Alasdair P. Macgowan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Bristol Centre for Antimicrobial Research and Evaluation, Infection Sciences, Severn Pathology Partnership, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, Bristol, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Bristol Centre for Antimicrobial Research and Evaluation, Infection Sciences, Severn Pathology Partnership, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, Bristol</wicri:regionArea>
<wicri:noRegion>Bristol</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Marriott, Deborah J E" sort="Marriott, Deborah J E" uniqKey="Marriott D" first="Deborah J E" last="Marriott">Deborah J E. Marriott</name>
<affiliation wicri:level="1">
<nlm:affiliation>St. Vincent's Hospital, Darlinghurst, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>St. Vincent's Hospital, Darlinghurst, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>University of New South Wales, Sydney, NSW, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of New South Wales, Sydney, NSW</wicri:regionArea>
<wicri:noRegion>NSW</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Muller, Anouk E" sort="Muller, Anouk E" uniqKey="Muller A" first="Anouk E" last="Muller">Anouk E. Muller</name>
<affiliation wicri:level="3">
<nlm:affiliation>HaaglandenMC, The Hague and ErasmusMC, Rotterdam, The Netherlands.</nlm:affiliation>
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>HaaglandenMC, The Hague and ErasmusMC, Rotterdam</wicri:regionArea>
<placeName>
<settlement type="city">Rotterdam</settlement>
<region nuts="2" type="province">Hollande-Méridionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nadrah, Kristina" sort="Nadrah, Kristina" uniqKey="Nadrah K" first="Kristina" last="Nadrah">Kristina Nadrah</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.</nlm:affiliation>
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.</nlm:affiliation>
<country xml:lang="fr">Slovénie</country>
<wicri:regionArea>Faculty of Medicine, University of Ljubljana, Ljubljana</wicri:regionArea>
<wicri:noRegion>Ljubljana</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Paterson, David L" sort="Paterson, David L" uniqKey="Paterson D" first="David L" last="Paterson">David L. Paterson</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Standing, Joseph F" sort="Standing, Joseph F" uniqKey="Standing J" first="Joseph F" last="Standing">Joseph F. Standing</name>
<affiliation wicri:level="4">
<nlm:affiliation>Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
<orgName type="university">University College de Londres</orgName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Pharmacy, Great Ormond Street Hospital for Children, London, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Pharmacy, Great Ormond Street Hospital for Children, London</wicri:regionArea>
<placeName>
<settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Telles, Joao P" sort="Telles, Joao P" uniqKey="Telles J" first="João P" last="Telles">João P. Telles</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP, Brazil.</nlm:affiliation>
<country xml:lang="fr">Brésil</country>
<wicri:regionArea>Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP</wicri:regionArea>
<placeName>
<region type="state">État de São Paulo</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wolfl Duchek, Michael" sort="Wolfl Duchek, Michael" uniqKey="Wolfl Duchek M" first="Michael" last="Wölfl-Duchek">Michael Wölfl-Duchek</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Department of Clinical Pharmacology, Medical University of Vienna, Vienna</wicri:regionArea>
<placeName>
<settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Thy, Michael" sort="Thy, Michael" uniqKey="Thy M" first="Michael" last="Thy">Michael Thy</name>
<affiliation wicri:level="3">
<nlm:affiliation>Infectious Diseases Department and Intensive Care Unit, Hospital Bichat, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Infectious Diseases Department and Intensive Care Unit, Hospital Bichat, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>EA7323, Evaluation of Perinatal and Paediatric Therapeutics and Pharmacology, University Paris Descartes, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>EA7323, Evaluation of Perinatal and Paediatric Therapeutics and Pharmacology, University Paris Descartes, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name>
<affiliation wicri:level="1">
<nlm:affiliation>University of Queensland Centre for Clinical Research, Faculty of Medicine and Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>University of Queensland Centre for Clinical Research, Faculty of Medicine and Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD</wicri:regionArea>
<wicri:noRegion>QLD</wicri:noRegion>
</affiliation>
<affiliation wicri:level="3">
<nlm:affiliation>Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes</wicri:regionArea>
<placeName>
<region type="region">Occitanie (région administrative)</region>
<region type="old region">Languedoc-Roussillon</region>
<settlement type="city">Nîmes</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="1">
<nlm:affiliation>The University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia. j.roberts2@uq.edu.au.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029</wicri:regionArea>
<wicri:noRegion>4029</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinical pharmacokinetics</title>
<idno type="eISSN">1179-1926</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">There is an urgent need to identify optimal antiviral therapies for COVID-19 caused by SARS-CoV-2. We have conducted a rapid and comprehensive review of relevant pharmacological evidence, focusing on (1) the pharmacokinetics (PK) of potential antiviral therapies; (2) coronavirus-specific pharmacodynamics (PD); (3) PK and PD interactions between proposed combination therapies; (4) pharmacology of major supportive therapies; and (5) anticipated drug-drug interactions (DDIs). We found promising in vitro evidence for remdesivir, (hydroxy)chloroquine and favipiravir against SARS-CoV-2; potential clinical benefit in SARS-CoV-2 with remdesivir, the combination of lopinavir/ritonavir (LPV/r) plus ribavirin; and strong evidence for LPV/r plus ribavirin against Middle East Respiratory Syndrome (MERS) for post-exposure prophylaxis in healthcare workers. Despite these emerging data, robust controlled clinical trials assessing patient-centred outcomes remain imperative and clinical data have already reduced expectations with regard to some drugs. Any therapy should be used with caution in the light of potential drug interactions and the uncertainty of optimal doses for treating mild versus serious infections.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32725382</PMID>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1179-1926</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Jul</Month>
<Day>28</Day>
</PubDate>
</JournalIssue>
<Title>Clinical pharmacokinetics</Title>
<ISOAbbreviation>Clin Pharmacokinet</ISOAbbreviation>
</Journal>
<ArticleTitle>Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s40262-020-00924-9</ELocationID>
<Abstract>
<AbstractText>There is an urgent need to identify optimal antiviral therapies for COVID-19 caused by SARS-CoV-2. We have conducted a rapid and comprehensive review of relevant pharmacological evidence, focusing on (1) the pharmacokinetics (PK) of potential antiviral therapies; (2) coronavirus-specific pharmacodynamics (PD); (3) PK and PD interactions between proposed combination therapies; (4) pharmacology of major supportive therapies; and (5) anticipated drug-drug interactions (DDIs). We found promising in vitro evidence for remdesivir, (hydroxy)chloroquine and favipiravir against SARS-CoV-2; potential clinical benefit in SARS-CoV-2 with remdesivir, the combination of lopinavir/ritonavir (LPV/r) plus ribavirin; and strong evidence for LPV/r plus ribavirin against Middle East Respiratory Syndrome (MERS) for post-exposure prophylaxis in healthcare workers. Despite these emerging data, robust controlled clinical trials assessing patient-centred outcomes remain imperative and clinical data have already reduced expectations with regard to some drugs. Any therapy should be used with caution in the light of potential drug interactions and the uncertainty of optimal doses for treating mild versus serious infections.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Zeitlinger</LastName>
<ForeName>Markus</ForeName>
<Initials>M</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-5500-5878</Identifier>
<AffiliationInfo>
<Affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Koch</LastName>
<ForeName>Birgit C P</ForeName>
<Initials>BCP</Initials>
<AffiliationInfo>
<Affiliation>Hospital Pharmacy, Erasmus MC, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Bruggemann</LastName>
<ForeName>Roger</ForeName>
<Initials>R</Initials>
<AffiliationInfo>
<Affiliation>Radboud University Medical Center, Nijmegen, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>De Cock</LastName>
<ForeName>Pieter</ForeName>
<Initials>P</Initials>
<AffiliationInfo>
<Affiliation>Department of Pharmacy 2, Heymans Institute of Pharmacology, Ghent University Hospital, Ghent University, Ghent, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Felton</LastName>
<ForeName>Timothy</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Intensive Care Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hites</LastName>
<ForeName>Maya</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Clinic of Infectious Diseases, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Le</LastName>
<ForeName>Jennifer</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, San Diego, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Luque</LastName>
<ForeName>Sonia</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Pharmacy Department, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar D'Investigacions Mèdiques (IMIM), Barcelona, Spain.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>MacGowan</LastName>
<ForeName>Alasdair P</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>Bristol Centre for Antimicrobial Research and Evaluation, Infection Sciences, Severn Pathology Partnership, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, Bristol, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Marriott</LastName>
<ForeName>Deborah J E</ForeName>
<Initials>DJE</Initials>
<AffiliationInfo>
<Affiliation>St. Vincent's Hospital, Darlinghurst, NSW, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>University of New South Wales, Sydney, NSW, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Muller</LastName>
<ForeName>Anouk E</ForeName>
<Initials>AE</Initials>
<AffiliationInfo>
<Affiliation>HaaglandenMC, The Hague and ErasmusMC, Rotterdam, The Netherlands.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nadrah</LastName>
<ForeName>Kristina</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, University Medical Centre Ljubljana, Ljubljana, Slovenia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Paterson</LastName>
<ForeName>David L</ForeName>
<Initials>DL</Initials>
<AffiliationInfo>
<Affiliation>University of Queensland Centre for Clinical Research, Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Standing</LastName>
<ForeName>Joseph F</ForeName>
<Initials>JF</Initials>
<AffiliationInfo>
<Affiliation>Infection, Inflammation and Immunity, Great Ormond Street Institute of Child Health, University College London, London, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, Great Ormond Street Hospital for Children, London, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Telles</LastName>
<ForeName>João P</ForeName>
<Initials>JP</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, AC Camargo Cancer Center, São Paulo, SP, Brazil.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wölfl-Duchek</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Thy</LastName>
<ForeName>Michael</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Infectious Diseases Department and Intensive Care Unit, Hospital Bichat, Paris, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>EA7323, Evaluation of Perinatal and Paediatric Therapeutics and Pharmacology, University Paris Descartes, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Roberts</LastName>
<ForeName>Jason A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo>
<Affiliation>University of Queensland Centre for Clinical Research, Faculty of Medicine and Centre for Translational Anti-Infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Pharmacy, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Department of Intensive Care Medicine, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia. j.roberts2@uq.edu.au.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France. j.roberts2@uq.edu.au.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>The University of Queensland Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital, Butterfield St, Herston, QLD, 4029, Australia. j.roberts2@uq.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<CollectiveName>PK/PD of Anti-Infectives Study Group (EPASG) of the European Society of Clinical Microbiology, Infectious Diseases (ESCMID)</CollectiveName>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>07</Month>
<Day>28</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Clin Pharmacokinet</MedlineTA>
<NlmUniqueID>7606849</NlmUniqueID>
<ISSNLinking>0312-5963</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>7</Month>
<Day>30</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32725382</ArticleId>
<ArticleId IdType="doi">10.1007/s40262-020-00924-9</ArticleId>
<ArticleId IdType="pii">10.1007/s40262-020-00924-9</ArticleId>
<ArticleId IdType="pmc">PMC7385074</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Cell Res. 2020 Mar;30(3):269-271</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32020029</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Med. 2006 Sep;3(9):e343</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16968120</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>ACS Omega. 2018 Dec 31;3(12):18132-18141</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30613818</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>JAMA. 2020 Jun 23;323(24):2493-2502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32392282</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Trop. 2002 Jul;83(1):49-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12062793</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS Negl Trop Dis. 2017 Feb 23;11(2):e0005389</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28231247</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2013 Apr;57(4):1743-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23357765</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hong Kong Med J. 2003 Dec;9(6):399-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14660806</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Blood Purif. 1993;11(2):99-107</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8274246</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2014 Jun;14(6):498-509</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24768475</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2014 Dec;44(6):528-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25288266</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2020 Jun;178:104786</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32251767</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 May 7;382(19):1787-1799</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32187464</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arthritis Care Res (Hoboken). 2016 Sep;68(9):1295-302</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26749299</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 30;395(10238):1695-1704</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32401715</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Med. 1983 Jul 18;75(1A):40-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6869410</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Hosp Infect. 2019 Jan;101(1):42-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30240813</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Drug Discov Ther. 2020;14(1):58-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32147628</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Clin Pharmacol. 2013 Feb 1;8(1):39-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22946871</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2006 May;43(5):943-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16761329</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS. 2001 Nov 23;15(17):2221-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11698694</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biosci Trends. 2020 Mar 16;14(1):64-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32037389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 1990 Nov;19(5):390-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1702693</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Jul 28;71(15):732-739</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32150618</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Drug Metab Toxicol. 2015;11(12):1803-19</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26419922</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Sep 3;383(10):994</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32649078</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2014 May;105:17-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24583123</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Travel Med Infect Dis. 2020 Mar - Apr;34:101663</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32289548</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Aug 6;383(6):517-525</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32492293</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Chin Med J (Engl). 2020 May 5;133(9):1132-1134</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32149772</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Pharm Ther. 2017 Dec;42(6):661-671</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28948652</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Thorax. 2004 Mar;59(3):252-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14985565</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Discov. 2020 Mar 18;6:16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32194981</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 2001;40(11):833-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11735605</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biomed Pharmacother. 2018 Mar;99:921-930</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29710492</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2012 Jan;84(1):170-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22028179</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 2007;46(12):997-1038</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18027987</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Acta Anaesthesiol Scand. 2001 Sep;45(8):929-34</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11576041</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2011 Feb;55(2):473-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21098255</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gen Virol. 2014 Mar;95(Pt 3):571-577</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24323636</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Pharmacokinet. 1998 Oct;35(4):275-91</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9812178</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Nephrol. 2011 Apr;7(4):226-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21343897</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biol Pharm Bull. 2008 Nov;31(11):1985-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18981560</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell Discov. 2020 May 2;6:28</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32373347</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Travel Med Infect Dis. 2020 May - Jun;35:101738</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32387409</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br J Clin Pharmacol. 2015 Apr;79(4):650-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25297637</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 Apr 15;70(9):1837-1844</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31925415</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2011 Jun;55(6):2775-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21422211</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Med Virol. 2020 Jun;92(6):556-563</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32104907</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Engineering (Beijing). 2020 Mar 18;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32346491</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2016 Mar 17;531(7594):381-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26934220</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Infect. 2013 Dec;67(6):606-16</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24096239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Commun. 2020 Jan 10;11(1):222</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31924756</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2005 Jan 28;326(4):905-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15607755</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AIDS. 2008 Oct 1;22(15):1919-27</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18784455</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Pharmacol. 2019 Feb;75(2):207-216</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30291369</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mil Med Res. 2020 Feb 6;7(1):4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32029004</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vet Pharmacol Ther. 2004 Dec;27(6):441-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15601439</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jun 18;382(25):2411-2418</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32379955</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Pharmacol Toxicol. 1998 Sep;83(3):135-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9783333</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antiviral Res. 2018 Mar;151:97-104</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29289666</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2014 Aug;58(8):4875-84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24841269</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Clin Pharmacol. 2012 Apr;68(4):415-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22037562</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Ther. 2018;23(5):457-461</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29185991</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Anal Bioanal Chem. 2008 Jun;391(3):1063-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18392693</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Lab Clin Med. 1976 Jul;88(1):87-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">932536</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Expert Opin Drug Discov. 2019 Apr;14(4):397-412</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30849247</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Crit Care. 2012 Dec;27(6):741.e9-18</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22520488</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet. 2020 Jun 13;395(10240):1820</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32511943</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Interferon Cytokine Res. 1999 Oct;19(10):1117-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10547151</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Infect Dis. 2020 May 21;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32435791</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Cell. 2020 Apr 16;181(2):271-280.e8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32142651</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Xenobiotica. 1994 Jan;24(1):79-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8165824</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antimicrob Agents Chemother. 2020 May 21;64(6):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32312781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ther Drug Monit. 1986;8(3):285-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3750371</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2003 Nov;3(11):722-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14592603</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 2020 Jul 17;:</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Antivir Ther. 2016;21(5):455-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26492219</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>World J Pediatr. 2020 Jun;16(3):223-231</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32034659</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Microbiol Infect. 2020 Jul;26(7):917-921</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32344167</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ther Adv Psychopharmacol. 2017 Dec;7(12):251-264</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29201344</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochem Biophys Res Commun. 2004 Jun 4;318(3):719-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15144898</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Antimicrob Chemother. 2016 Jun;71(6):1597-600</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26869690</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Gastroenterol. 2014 Mar;49(3):388-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23720090</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Opin Infect Dis. 2019 Apr;32(2):176-186</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30724789</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Virol. 2004 Sep;31(1):69-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15288617</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Lancet Infect Dis. 2014 Nov;14(11):1090-1095</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25278221</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Clin Pharmacol Ther. 2013 May;51(5):423-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23391367</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>Autriche</li>
<li>Belgique</li>
<li>Brésil</li>
<li>Espagne</li>
<li>France</li>
<li>Pays-Bas</li>
<li>Royaume-Uni</li>
<li>Slovénie</li>
<li>États-Unis</li>
</country>
<region>
<li>Angleterre</li>
<li>Californie</li>
<li>Catalogne</li>
<li>Grand Londres</li>
<li>Grand Manchester</li>
<li>Gueldre</li>
<li>Hollande-Méridionale</li>
<li>Languedoc-Roussillon</li>
<li>Occitanie (région administrative)</li>
<li>Région de Bruxelles-Capitale</li>
<li>Vienne (Autriche)</li>
<li>État de São Paulo</li>
<li>Île-de-France</li>
</region>
<settlement>
<li>Barcelone</li>
<li>Bruxelles</li>
<li>Londres</li>
<li>Manchester</li>
<li>Nimègue</li>
<li>Nîmes</li>
<li>Paris</li>
<li>Rotterdam</li>
<li>Vienne (Autriche)</li>
</settlement>
<orgName>
<li>University College de Londres</li>
<li>Université de Manchester</li>
<li>Université libre de Bruxelles</li>
</orgName>
</list>
<tree>
<country name="Autriche">
<region name="Vienne (Autriche)">
<name sortKey="Zeitlinger, Markus" sort="Zeitlinger, Markus" uniqKey="Zeitlinger M" first="Markus" last="Zeitlinger">Markus Zeitlinger</name>
</region>
<name sortKey="Wolfl Duchek, Michael" sort="Wolfl Duchek, Michael" uniqKey="Wolfl Duchek M" first="Michael" last="Wölfl-Duchek">Michael Wölfl-Duchek</name>
</country>
<country name="Pays-Bas">
<region name="Hollande-Méridionale">
<name sortKey="Koch, Birgit C P" sort="Koch, Birgit C P" uniqKey="Koch B" first="Birgit C P" last="Koch">Birgit C P. Koch</name>
</region>
<name sortKey="Bruggemann, Roger" sort="Bruggemann, Roger" uniqKey="Bruggemann R" first="Roger" last="Bruggemann">Roger Bruggemann</name>
<name sortKey="Muller, Anouk E" sort="Muller, Anouk E" uniqKey="Muller A" first="Anouk E" last="Muller">Anouk E. Muller</name>
</country>
<country name="Belgique">
<noRegion>
<name sortKey="De Cock, Pieter" sort="De Cock, Pieter" uniqKey="De Cock P" first="Pieter" last="De Cock">Pieter De Cock</name>
</noRegion>
<name sortKey="Hites, Maya" sort="Hites, Maya" uniqKey="Hites M" first="Maya" last="Hites">Maya Hites</name>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Felton, Timothy" sort="Felton, Timothy" uniqKey="Felton T" first="Timothy" last="Felton">Timothy Felton</name>
</region>
<name sortKey="Felton, Timothy" sort="Felton, Timothy" uniqKey="Felton T" first="Timothy" last="Felton">Timothy Felton</name>
<name sortKey="Macgowan, Alasdair P" sort="Macgowan, Alasdair P" uniqKey="Macgowan A" first="Alasdair P" last="Macgowan">Alasdair P. Macgowan</name>
<name sortKey="Standing, Joseph F" sort="Standing, Joseph F" uniqKey="Standing J" first="Joseph F" last="Standing">Joseph F. Standing</name>
<name sortKey="Standing, Joseph F" sort="Standing, Joseph F" uniqKey="Standing J" first="Joseph F" last="Standing">Joseph F. Standing</name>
</country>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Le, Jennifer" sort="Le, Jennifer" uniqKey="Le J" first="Jennifer" last="Le">Jennifer Le</name>
</region>
</country>
<country name="Espagne">
<region name="Catalogne">
<name sortKey="Luque, Sonia" sort="Luque, Sonia" uniqKey="Luque S" first="Sonia" last="Luque">Sonia Luque</name>
</region>
<name sortKey="Luque, Sonia" sort="Luque, Sonia" uniqKey="Luque S" first="Sonia" last="Luque">Sonia Luque</name>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Marriott, Deborah J E" sort="Marriott, Deborah J E" uniqKey="Marriott D" first="Deborah J E" last="Marriott">Deborah J E. Marriott</name>
</noRegion>
<name sortKey="Marriott, Deborah J E" sort="Marriott, Deborah J E" uniqKey="Marriott D" first="Deborah J E" last="Marriott">Deborah J E. Marriott</name>
<name sortKey="Paterson, David L" sort="Paterson, David L" uniqKey="Paterson D" first="David L" last="Paterson">David L. Paterson</name>
<name sortKey="Paterson, David L" sort="Paterson, David L" uniqKey="Paterson D" first="David L" last="Paterson">David L. Paterson</name>
<name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name>
<name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name>
<name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name>
<name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name>
</country>
<country name="Slovénie">
<noRegion>
<name sortKey="Nadrah, Kristina" sort="Nadrah, Kristina" uniqKey="Nadrah K" first="Kristina" last="Nadrah">Kristina Nadrah</name>
</noRegion>
<name sortKey="Nadrah, Kristina" sort="Nadrah, Kristina" uniqKey="Nadrah K" first="Kristina" last="Nadrah">Kristina Nadrah</name>
</country>
<country name="Brésil">
<region name="État de São Paulo">
<name sortKey="Telles, Joao P" sort="Telles, Joao P" uniqKey="Telles J" first="João P" last="Telles">João P. Telles</name>
</region>
</country>
<country name="France">
<region name="Île-de-France">
<name sortKey="Thy, Michael" sort="Thy, Michael" uniqKey="Thy M" first="Michael" last="Thy">Michael Thy</name>
</region>
<name sortKey="Roberts, Jason A" sort="Roberts, Jason A" uniqKey="Roberts J" first="Jason A" last="Roberts">Jason A. Roberts</name>
<name sortKey="Thy, Michael" sort="Thy, Michael" uniqKey="Thy M" first="Michael" last="Thy">Michael Thy</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000951 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000951 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32725382
   |texte=   Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32725382" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021